
Priveterra Acquisition
PMGM | NASDAQ
$11.05
-$0.01 (-0.09%)
At close: May 09, 2024, 04:00 PM ET
Priveterra Acquisition Company Profile
Company profile explainedCompany Profile
Priveterra Acquisition Corp. presently does not conduct significant business activities. The company's main goal is to finalize a strategic business combination, such as a merger, a share exchange, an asset purchase, an equity acquisition, a corporate restructuring, or a comparable transaction, with one or more entities. Its acquisition strategy is focused on companies within the medical technology industry. The firm was established in 2020 and has its principal executive offices in Fort Lauderdale, Florida.
Key Executives
| Name | Position |
|---|---|
| Oleg Grodnensky | Chief Executive Officer & Chairman of the Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 30, 2026 | 8-K | Current Report |
| Aug 21, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 21, 2026 | 4 | Filing |
| Aug 21, 2026 | 3 | Filing |
| Aug 12, 2026 | 10-Q | Quarterly Report |
| Aug 12, 2026 | 8-K | Current Report |
| Aug 03, 2026 | 8-K | Current Report |
| Jul 23, 2026 | 8-K | Current Report |
| Jul 21, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jul 15, 2026 | 8-K | Current Report |
Priveterra Acquisition

| Country | United States |
| IPO Date | Apr 12, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | 5 |
| CEO | Oleg Grodnensky |
Contact Details
300 SE 2nd Street Fort Lauderdale,
Florida 33301 United States
Stock Details
| Ticker Symbol | PMGM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001837607 |
| CUSIP Number | 74275N102 |
| ISIN Number | US74275N1028 |
| SIC Code | 6770 |
Add to Watchlist
Select watchlists to add or remove PMGM